118 related articles for article (PubMed ID: 18523284)
1. NK cell protease granzyme M targets alpha-tubulin and disorganizes the microtubule network.
Bovenschen N; de Koning PJ; Quadir R; Broekhuizen R; Damen JM; Froelich CJ; Slijper M; Kummer JA
J Immunol; 2008 Jun; 180(12):8184-91. PubMed ID: 18523284
[TBL] [Abstract][Full Text] [Related]
2. Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell death.
de Koning PJ; Kummer JA; de Poot SA; Quadir R; Broekhuizen R; McGettrick AF; Higgins WJ; Devreese B; Worrall DM; Bovenschen N
PLoS One; 2011; 6(8):e22645. PubMed ID: 21857942
[TBL] [Abstract][Full Text] [Related]
3. Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71.
van Domselaar R; Philippen LE; Quadir R; Wiertz EJ; Kummer JA; Bovenschen N
J Immunol; 2010 Dec; 185(12):7605-13. PubMed ID: 21059895
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics.
Adrain C; Duriez PJ; Brumatti G; Delivani P; Martin SJ
J Biol Chem; 2006 Mar; 281(12):8118-25. PubMed ID: 16415351
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
[TBL] [Abstract][Full Text] [Related]
6. Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.
de Poot SA; Lai KW; van der Wal L; Plasman K; Van Damme P; Porter AC; Gevaert K; Bovenschen N
Cell Death Differ; 2014 Mar; 21(3):416-26. PubMed ID: 24185622
[TBL] [Abstract][Full Text] [Related]
7. HtrA3 is a cellular partner of cytoskeleton proteins and TCP1α chaperonin.
Wenta T; Zurawa-Janicka D; Rychlowski M; Jarzab M; Glaza P; Lipinska A; Bienkowska-Szewczyk K; Herman-Antosiewicz A; Skorko-Glonek J; Lipinska B
J Proteomics; 2018 Apr; 177():88-111. PubMed ID: 29477555
[TBL] [Abstract][Full Text] [Related]
8. Human and mouse granzyme M display divergent and species-specific substrate specificities.
de Poot SA; Westgeest M; Hostetter DR; Van Damme P; Plasman K; Demeyer K; Broekhuizen R; Gevaert K; Craik CS; Bovenschen N
Biochem J; 2011 Aug; 437(3):431-42. PubMed ID: 21564021
[TBL] [Abstract][Full Text] [Related]
9. Granzyme M: behind enemy lines.
de Poot SA; Bovenschen N
Cell Death Differ; 2014 Mar; 21(3):359-68. PubMed ID: 24413154
[TBL] [Abstract][Full Text] [Related]
10. Controversies in granzyme biology.
Susanto O; Trapani JA; Brasacchio D
Tissue Antigens; 2012 Dec; 80(6):477-87. PubMed ID: 23137319
[TBL] [Abstract][Full Text] [Related]
11. Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A.
Bovenschen N; Quadir R; van den Berg AL; Brenkman AB; Vandenberghe I; Devreese B; Joore J; Kummer JA
J Biol Chem; 2009 Feb; 284(6):3504-12. PubMed ID: 19059912
[TBL] [Abstract][Full Text] [Related]
12. Identification of {alpha}-tubulin as a granzyme B substrate during CTL-mediated apoptosis.
Goping IS; Sawchuk T; Underhill DA; Bleackley RC
J Cell Sci; 2006 Mar; 119(Pt 5):858-65. PubMed ID: 16495481
[TBL] [Abstract][Full Text] [Related]
13. Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.
Scott GB; Bowles PA; Wilson EB; Meade JL; Low BC; Davison A; Blair GE; Cook GP
Biochem J; 2010 Nov; 431(3):423-31. PubMed ID: 20704564
[TBL] [Abstract][Full Text] [Related]
14. Functional role of phosphatidylinositol 3-kinase in direct tumor lysis by human natural killer cells.
Zhong B; Liu JH; Gilvary DL; Jiang K; Kasuga M; Ritchey CA; Trapani JA; Wei S
Immunobiology; 2002 Mar; 205(1):74-94. PubMed ID: 11999346
[TBL] [Abstract][Full Text] [Related]
15. Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation.
Bovenschen N; Spijkers SN; Wensink AC; Schellens IM; van Domselaar R; van Baarle D
Clin Immunol; 2014 Jan; 150(1):1-11. PubMed ID: 24316590
[TBL] [Abstract][Full Text] [Related]
16. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2.
Wei S; Gamero AM; Liu JH; Daulton AA; Valkov NI; Trapani JA; Larner AC; Weber MJ; Djeu JY
J Exp Med; 1998 Jun; 187(11):1753-65. PubMed ID: 9607917
[TBL] [Abstract][Full Text] [Related]
17. HLA-B2702 (77-83/83-77) peptide binds to beta-tubulin on human NK cells and blocks their cytotoxic capacity.
Tarazona R; López-Lluch G; Galiani MD; Aguado E; Barahona F; Solana R; Peña J
J Immunol; 2000 Dec; 165(12):6776-82. PubMed ID: 11120798
[TBL] [Abstract][Full Text] [Related]
18. In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1.
Jones GJ; Wiseman JC; Marr KJ; Wei S; Djeu JY; Mody CH
Int Immunol; 2009 Apr; 21(4):423-32. PubMed ID: 19261694
[TBL] [Abstract][Full Text] [Related]
19. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythms of granzyme B, perforin, IFN-gamma, and NK cell cytolytic activity in the spleen: effects of chronic ethanol.
Arjona A; Boyadjieva N; Sarkar DK
J Immunol; 2004 Mar; 172(5):2811-7. PubMed ID: 14978081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
